Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models-Reference-Cited by-同舟云学术

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models

Published:2019-06-17 Issue:12 Volume:60 Page:3067-3070
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Astorgues-Xerri Lucile¹,Vázquez Ramiro²,Odore Elodie³,Rezai Keyvan³,Kahatt Carmen¹,Mackenzie Sarah¹,Bekradda Mohamed¹,Coudé Marie-Magdelaine⁴,Dombret Herve⁴,Gardin Claude⁴,Lokiec Francois³,Raymond Eric⁵,Noel Kay⁶,Cvitkovic Esteban⁶,Herait Patrice⁶,Bertoni Francesco²,Riveiro María E.¹

Affiliation:

1. Oncology Therapeutic Development, Clichy, France;

2. Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland;

3. RadioPharmacology Department, Curie Institute–Rene Huguenin Hospital, Saint Cloud, France;

4. Laboratoire de Transfert des Leucémies, Université Paris Diderot, Paris, France;

5. Medical Oncology Department, CHUV, Lausanne, Switzerland;

6. Oncoethix SA, Lucerne, Switzerland

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link